Skip to main content
. 2021 Jul 10;33(1):95–105. doi: 10.1007/s00192-021-04920-w

Table 4.

Prevalence of overactive bladder symptoms at baseline per stages of individual compartments

Symptom Compartment Stage Any degree of bothera Bothersome symptomb
n with symptom/n total % (95% CI) n with symptom/n total % (95% CI)
Frequency Anterior 0 264/444 59.5 (54.7–64.1) 116/444 26.1 (22.1–30.5)
1 184/298 61.7 (56.0–67.3) 85/298 28.5 (23.5–34.0)
2 785/1157 67.8 (65.1–70.5) 349/1157 30.2 (27.5–32.9)
3–4 602/831 72.4 (69.3–75.5) 303/831 36.5 (33.2–39.8)
Posterior 0 492/700 70.3 (66.7–73.7) 231/700 33.0 (29.5–36.6)
1 312/434 71.9 (67.4–76.1) 135/434 31.1 (26.8–35.7)
2 759/1183 64.2 (61.4–66.9) 350/1183 29.6 (27.0–32.3)
3–4 259/404 64.1 (59.2–68.8) 130/404 32.2 (27.6–37.0)
Apex 0–1 858/1330 64.5 (61.9–67.1) 379/1330 28.5 (26.1–31.0)
2 633/911 69.5 (66.4–72.5) 300/911 32.9 (29.9–36.1)
3–4 324/456 71.1 (66.7–75.2) 162/456 35.5 (31.1–40.1)
UUI Anterior 0 224/449 49.9 (45.2–54.6) 90/449 20.0 (16.4–24.1)
1 169/298 56.7 (50.9–62.4) 85/298 28.5 (23.5–34.0)
2 769/1161 66.2 (63.4–69.0) 313/1161 27.0 (25.8–32.1)
3–4 554/842 65.8 (62.5–69.0) 243/842 28.9 (25.8–32.1)
Posterior 0 470/709 66.3 (62.7–69.8) 212/709 29.9 (26.6–33.4)
1 299/438 68.3 (63.7–72.6) 108/438 24.7 (20.7–29.0)
2 697/1187 58.7 (55.9–61.5) 299/1187 25.2 (22.7–27.8)
3–4 233/408 57.1 (52.1–62.0) 105/408 25.7 (21.6–30.3)
Apex 0–1 826/1352 61.1 (58.4–63.7) 343/1352 25.4 (23.1–27.8)
2 585/903 64.8 (61.6–67.9) 261/903 28.9 (26.0–32.0)
3–4 278/463 60.0 (55.4–64.5) 114/463 24.6 (20.8–28.8)

CI, confidence interval; UUI, urgency urinary incontinence

aAnswer ‘Yes’ in PFDI-20 questionnaire; bbothersome symptom defined as answers 3: moderately and 4: quite a bit in PFDI-20 questionnaire (Scale = 0–4)